Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation

NCT07483385 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Patients With Hematologic Disorders After Allogeneic Hematopoietic Stem Cell Transplantation
Hematologic Disorders

Interventions

DRUG: Lusutrombopag

Sponsor

The General Hospital of Western Theater Command